EUVIMEDEUVIMED entdecken
Crossref

Single agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study

E zzat Safwat

Research in Oncology · 2007

DOI: 10.21608/resoncol.2007.372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Oncology, 2007. Verfasst von E zzat Safwat.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Safwat, E. Z. (2007). Single agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study. Research in Oncology. https://doi.org/10.21608/resoncol.2007.372

Vancouver

Safwat EZ. Single agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study. Research in Oncology. 2007. doi:10.21608/resoncol.2007.372

BibTeX
@article{Safwat2007,
  author = {Safwat, E zzat},
  title = {Single agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study},
  journal = {Research in Oncology},
  year = {2007},
  doi = {10.21608/resoncol.2007.372}
}
Kostenlos starten →